A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT03164057 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

206

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: Azacitidine
DRUG: Decitabine
DRUG: Cytarabine
DRUG: Daunorubicin
DRUG: Etoposide
COMBINATION_PRODUCT: ITMHA
DRUG: Idarubicin
DRUG: Fludarabine
DRUG: Mitoxantrone
DRUG: Erwinia asparaginase
DRUG: Sorafenib
DRUG: G-CSF
DRUG: Dexrazoxane
BIOLOGICAL: Stem Cell Transplant
DRUG: Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn

Sponsor

St. Jude Children's Research Hospital